Recombinant Chelyosoma productum Gonadoliberin-1

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format. If you have format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins ship with blue ice packs. For dry ice shipping, contact us in advance (extra fees apply).
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
Gonadoliberin-1; Gonadoliberin I; Gonadotropin-releasing hormone I; GnRH-I; Luliberin I
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-10
Protein Length
Cytoplasmic domain
Purity
>85% (SDS-PAGE)
Species
Chelyosoma productum (Solitary ascidian)
Target Protein Sequence
QHWSDYFKPG
Uniprot No.

Target Background

Function
Stimulates gonadotropin secretion, including luteinizing and follicle-stimulating hormones.
Protein Families
GnRH family
Subcellular Location
Secreted.
Tissue Specificity
GNRH neurons lie within blood sinuses close to the gonoducts and gonads in both juveniles and adults, implying that the neuropeptide is released into the bloodstream.

Q&A

Given the lack of specific information on "Recombinant Chelyosoma productum Gonadoliberin-1" in the search results, I will create a collection of FAQs that are relevant to the broader context of gonadoliberin (GnRH) research, focusing on experimental design and methodological aspects. This approach will provide a framework for researchers interested in studying similar compounds.

Data Analysis for Contradictory Findings

  • Question: How do researchers address contradictory data when studying gonadoliberin's effects on LH release?

  • Answer: Contradictory findings can be addressed by ensuring rigorous experimental controls, using multiple analytical methods (e.g., both molecular and physiological assays), and considering factors like age, sex, and hormonal status of the subjects. Statistical analysis should include tests for significance and post-hoc analyses to identify specific differences between treatment groups .

Advanced Research Questions: Mechanisms of Action

  • Question: What are some advanced research questions regarding the mechanisms of action of gonadoliberin?

  • Answer: Advanced research questions might include investigating how gonadoliberin interacts with kisspeptin neurons to regulate LH release, or studying the role of GnRH metabolites like GnRH(1-5) in modulating reproductive functions. This involves using techniques like confocal microscopy to visualize co-expression of relevant genes in brain sections .

Methodological Considerations for Gene Expression Studies

  • Question: What methodological considerations are crucial when studying gene expression changes induced by gonadoliberin?

  • Answer: Crucial considerations include using appropriate primer pairs for real-time PCR, ensuring specificity of probes for in situ hybridization, and validating gene expression data through melt curve analysis and sequencing of amplified products. Additionally, using controls like mature adult tissues can help standardize assays .

Integration of New Technologies in Research

  • Question: How can researchers integrate new technologies (e.g., advanced sequencing techniques) into studies of gonadoliberin's effects?

  • Answer: New technologies like RNA sequencing can be used to comprehensively analyze changes in gene expression profiles following gonadoliberin administration. This allows for the identification of novel targets or pathways involved in its mechanism of action. Data should be deposited in public databases to facilitate collaboration and validation .

Comparative Studies Across Species

  • Question: How can researchers design comparative studies to explore the evolutionary conservation of gonadoliberin's functions across different species?

  • Answer: Comparative studies can involve using similar experimental designs across different species (e.g., rodents and birds) to assess whether gonadoliberin's effects on reproductive physiology are conserved. This might include comparing gene expression patterns or physiological responses to gonadoliberin administration .

Addressing Variability in Experimental Outcomes

  • Question: How can researchers address variability in experimental outcomes when studying gonadoliberin's effects?

  • Answer: Variability can be addressed by ensuring consistent experimental conditions, using large sample sizes, and employing statistical methods that account for individual differences. Additionally, using multiple replicates and controls helps to minimize variability and increase the reliability of findings .

Future Directions in Gonadoliberin Research

  • Question: What are some future directions for research on gonadoliberin and related compounds?

  • Answer: Future research could focus on elucidating the role of GnRH metabolites in reproductive regulation, exploring the therapeutic potential of gonadoliberin analogs, and investigating how environmental factors influence gonadoliberin's effects on reproductive physiology. This might involve interdisciplinary approaches combining molecular biology, physiology, and environmental science .

Data Table Example: Gene Expression Changes Following Gonadoliberin Administration

GeneRegionControl GroupTreatment Group
GnRH1Hypothalamus100 ± 10150 ± 15
Kiss1ARC50 ± 575 ± 8
Gpr101AVPV20 ± 230 ± 3

This table illustrates how gene expression changes can be quantitatively assessed following gonadoliberin administration, using techniques like real-time PCR or ISH.

Detailed Research Findings

Research on gonadoliberin has shown that it plays a crucial role in regulating LH release and reproductive functions. Studies have demonstrated that GnRH(1-5), a metabolite of gonadoliberin, can modulate LH release via kisspeptin neurons . Advanced research questions focus on understanding the molecular mechanisms underlying these effects and exploring potential therapeutic applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.